share_log

6-K: Report of foreign private issuer (related to financial reporting)

6-K: Report of foreign private issuer (related to financial reporting)

6-K:外国发行人报告(业绩相关)
美股SEC公告 ·  07/01 16:34

Moomoo AI 已提取核心信息

TC BioPharm (Holdings) PLC, a foreign private issuer, filed a Form 6-K with the SEC for July 2024, indicating the indefinite adjournment of its first 2024 Annual General Meeting (AGM) due to insufficient quorum as per Nasdaq rules. The company, having satisfied UK quorum requirements, announced a second AGM scheduled for July 24, 2024, at its UK office. Shareholders of record as of July 22, 2024, are entitled to vote, with ADS holders voting by proxy before July 19, 2024. The agenda includes receiving the annual report, approving directors' remuneration, ratifying the appointment of Marcum LLP as the U.S. auditor, re-appointing Ecovis as the UK auditor, and authorizing the Audit Committee to determine auditor remuneration.
TC BioPharm (Holdings) PLC, a foreign private issuer, filed a Form 6-K with the SEC for July 2024, indicating the indefinite adjournment of its first 2024 Annual General Meeting (AGM) due to insufficient quorum as per Nasdaq rules. The company, having satisfied UK quorum requirements, announced a second AGM scheduled for July 24, 2024, at its UK office. Shareholders of record as of July 22, 2024, are entitled to vote, with ADS holders voting by proxy before July 19, 2024. The agenda includes receiving the annual report, approving directors' remuneration, ratifying the appointment of Marcum LLP as the U.S. auditor, re-appointing Ecovis as the UK auditor, and authorizing the Audit Committee to determine auditor remuneration.
2024年7月,外国私募发行人TC BioPharm (Holdings) PLC向SEC提交6-K表格,根据Nasdaq规则,指示其第一个2024年年度股东大会(AGM)因缺乏法定人数而无限期休会。该公司已满足英国法定人数要求,并宣布将于2024年7月24日在其英国办事处召开第二次股东大会。截至2024年7月22日的股东登记将有权投票,ADS持有人可在2024年7月19日前通过代理投票。议程包括接收年度报告,批准董事报酬,批准美国审计师Marcum LLP的任命,重新任命英国审计师Ecovis,并授权审计委员会判断审计师报酬。
2024年7月,外国私募发行人TC BioPharm (Holdings) PLC向SEC提交6-K表格,根据Nasdaq规则,指示其第一个2024年年度股东大会(AGM)因缺乏法定人数而无限期休会。该公司已满足英国法定人数要求,并宣布将于2024年7月24日在其英国办事处召开第二次股东大会。截至2024年7月22日的股东登记将有权投票,ADS持有人可在2024年7月19日前通过代理投票。议程包括接收年度报告,批准董事报酬,批准美国审计师Marcum LLP的任命,重新任命英国审计师Ecovis,并授权审计委员会判断审计师报酬。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息